EP 1546715 A4 20070110 - METHOD FOR EVALUATING DRUG CANDIDATES
Title (en)
METHOD FOR EVALUATING DRUG CANDIDATES
Title (de)
VERFAHREN ZUR BEURTEILUNG VON ARZNEISTOFFKANDIDATEN
Title (fr)
METHODE D'EVALUATION DE CANDIDATS-MEDICAMENTS
Publication
Application
Priority
- US 0312434 W 20030423
- US 37451502 P 20020423
Abstract (en)
[origin: WO03091693A2] Two-dimensional and/or three-dimensional polymeric or extended solid arrays, such as arrays of a polydiacetylene backbone, are used to evaluate the organic/water partition coefficient and/or oral absorptivity and/or transcellular permeability of a compound by monitoring the change in the fluorescence or phosphorescence of the array upon exposure to the compound and comparing it to a known change in fluorescence or phosphorescence, respectively. The method can also be used to evaluate the ability of a compound to bind to a protein.
IPC 8 full level
G01N 33/53 (2006.01); G01N 33/542 (2006.01); G01N 33/544 (2006.01)
IPC 8 main group level
G01N (2006.01)
CPC (source: EP US)
G01N 33/542 (2013.01 - EP US); G01N 33/544 (2013.01 - EP US)
Citation (search report)
- [X] WO 9625665 A1 19960822 - UNIV CALIFORNIA [US]
- [A] WO 9502183 A1 19950119 - BIOCIRCUITS CORP [US]
- [T] WO 2006017821 A2 20060216 - ANALYTICAL BIOLOG SERVICES INC [US], et al
- See references of WO 03091693A2
Citation (examination)
J. RUELL: "Membrane based drug assays", MODERN DRUG DISCOVERY, 1 January 2003 (2003-01-01), Americal Chemical Society, St. Louis, MO USA, pages 28 - 30
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03091693 A2 20031106; WO 03091693 A3 20050506; AU 2003234171 A1 20031110; AU 2003234171 A8 20031110; EP 1546715 A2 20050629; EP 1546715 A4 20070110; US 2004023303 A1 20040205; US 2009062141 A1 20090305
DOCDB simple family (application)
US 0312434 W 20030423; AU 2003234171 A 20030423; EP 03728479 A 20030423; US 20275808 A 20080902; US 42080703 A 20030423